ID   HIPK1_RAT               Reviewed;        1211 AA.
AC   A4L9P5; A4L9P6;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 1.
DT   24-JUL-2024, entry version 90.
DE   RecName: Full=Homeodomain-interacting protein kinase 1;
DE            EC=2.7.11.1;
GN   Name=Hipk1 {ECO:0000312|EMBL:ABO47653.1};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:ABO47653.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Hagemann C., Stojic J., Weigelin B., Kessler A., Roosen K., Vince G.H.;
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in transcription
CC       regulation and TNF-mediated cellular apoptosis. Plays a role as a
CC       corepressor for homeodomain transcription factors. Phosphorylates DAXX
CC       and MYB. Phosphorylates DAXX in response to stress, and mediates its
CC       translocation from the nucleus to the cytoplasm. Inactivates MYB
CC       transcription factor activity by phosphorylation. Prevents MAP3K5-JNK
CC       activation in the absence of TNF. TNF triggers its translocation to the
CC       cytoplasm in response to stress stimuli, thus activating nuclear
CC       MAP3K5-JNK by derepression and promoting apoptosis. May be involved in
CC       anti-oxidative stress responses. Involved in the regulation of eye
CC       size, lens formation and retinal lamination during late embryogenesis.
CC       Promotes angiogenesis and to be involved in erythroid differentiation.
CC       May be involved in malignant squamous cell tumor formation (By
CC       similarity). Phosphorylates PAGE4 at 'Thr-51' which is critical for the
CC       ability of PAGE4 to potentiate the transcriptional activator activity
CC       of JUN (By similarity). {ECO:0000250|UniProtKB:Q86Z02}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O88904};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:O88904};
CC   -!- SUBUNIT: Interacts with Nkx1-2, Nkx2-5, MYB, PARK7, DAXX and p53/TP53.
CC       Part of a cytoplasmic complex made of HIPK1, DAB2IP and MAP3K5 in
CC       response to TNF. This complex formation promotes MAP3K5-JNK activation
CC       and subsequent apoptosis (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O88904}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O88904}. Nucleus speckle
CC       {ECO:0000250|UniProtKB:O88904}. Note=Predominantly nuclear.
CC       Translocates from nucleus to cytoplasm in response to stress stimuli
CC       via SENP1-mediated desumoylation (By similarity).
CC       {ECO:0000250|UniProtKB:O88904}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A4L9P5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A4L9P5-2; Sequence=VSP_052489;
CC   -!- PTM: Phosphorylated and activated by JNK1. Autophosphorylated (By
CC       similarity). {ECO:0000250|UniProtKB:Q86Z02}.
CC   -!- PTM: Sumoylated. When conjugated it is directed to nuclear speckles.
CC       SENP1-mediated desumoylation is mediated by TNF in response to stress
CC       stimuli, triggering transient translocation from nucleus to cytoplasm
CC       (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. HIPK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF460311; ABO47653.1; -; mRNA.
DR   EMBL; EF460312; ABO47654.1; -; mRNA.
DR   AlphaFoldDB; A4L9P5; -.
DR   SMR; A4L9P5; -.
DR   IntAct; A4L9P5; 1.
DR   MINT; A4L9P5; -.
DR   STRING; 10116.ENSRNOP00000061079; -.
DR   CarbonylDB; A4L9P5; -.
DR   iPTMnet; A4L9P5; -.
DR   PhosphoSitePlus; A4L9P5; -.
DR   PaxDb; 10116-ENSRNOP00000061079; -.
DR   PeptideAtlas; A4L9P5; -.
DR   UCSC; RGD:1304941; rat. [A4L9P5-1]
DR   AGR; RGD:1304941; -.
DR   RGD; 1304941; Hipk1.
DR   eggNOG; KOG0667; Eukaryota.
DR   InParanoid; A4L9P5; -.
DR   PhylomeDB; A4L9P5; -.
DR   Reactome; R-RNO-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   PRO; PR:A4L9P5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0016605; C:PML body; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0034333; P:adherens junction assembly; ISO:RGD.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0072577; P:endothelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISO:RGD.
DR   GO; GO:0061072; P:iris morphogenesis; ISO:RGD.
DR   GO; GO:0060235; P:lens induction in camera-type eye; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010803; P:regulation of tumor necrosis factor-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0010842; P:retina layer formation; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   CDD; cd14228; STKc_HIPK1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050494; Ser_Thr_dual-spec_kinase.
DR   PANTHER; PTHR24058; DUAL SPECIFICITY PROTEIN KINASE; 1.
DR   PANTHER; PTHR24058:SF43; HOMEODOMAIN-INTERACTING PROTEIN KINASE 1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Isopeptide bond; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..1211
FT                   /note="Homeodomain-interacting protein kinase 1"
FT                   /id="PRO_0000296298"
FT   DOMAIN          190..518
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          835..856
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          885..1094
FT                   /note="Interaction with TP53"
FT                   /evidence="ECO:0000250|UniProtKB:O88904"
FT   REGION          891..998
FT                   /note="Required for localization to nuclear speckles"
FT                   /evidence="ECO:0000250"
FT   REGION          902..926
FT                   /note="SUMO interaction motifs (SIM); required for nuclear
FT                   localization and kinase activity"
FT                   /evidence="ECO:0000250"
FT   REGION          1002..1023
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1047..1070
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1085..1105
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           844..847
FT                   /note="Nuclear localization signal 1 (NLS1)"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        315
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         196..204
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         219
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         872
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   MOD_RES         1201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   CROSSLNK        25
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        25
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   CROSSLNK        120
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   CROSSLNK        124
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   CROSSLNK        991
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q86Z02"
FT   CROSSLNK        1204
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         552..585
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_052489"
SQ   SEQUENCE   1211 AA;  130801 MW;  EB1ABD970F71BDF4 CRC64;
     MASQLQVFSP PSVSSSAFCS AKKLKIEPSG WDVSGQSSND KYYTHSKTLP ATQGQASSSH
     QVANFNIPAY DQGLLLQAPA VEHIVVTAAD SSGSAATATF QSSQTLTHRS NVSLLEPYQK
     CGLKRKSEEV DSNGSVQIIE EHPPLMLQNR TVVGAAATTT TVTTKSSSSS GEGDYQLVQH
     EILCSMTNSY EVLEFLGRGT FGQVAKCWKR STKEIVAIKI LKNHPSYARQ GQIEVSILSR
     LSSENADEYN FVRSYECFQH KNHTCLVFEM LEQNLYDFLK QNKFSPLPLK YIRPILQQVA
     TALMKLKSLG LIHADLKPEN IMLVDPVRQP YRVKVIDFGS ASHVSKAVCS TYLQSRYYRA
     PEIILGLPFC EAIDMWSLGC VIAELFLGWP LYPGASEYDQ IRYISQTQGL PAEYLLSAGT
     KTTRFFNRDP NLGYPLWRLK TPEEHELETG IKSKEARKYI FNCLDDMAQV NMSTDLEGTD
     MLAEKADRRE YIDLLKKMLT IDADKRVTPL KTLNHQFVTM THLLDFPHSN HVKSCFQNME
     ICKRRVHMYD TVSQIKSPFT THVAPSTSTN LTMSFSNQLS TVHNQASVLA SSSTAAAATL
     SLANSDVSLL NYQSALYPPS AAPVPGVAQQ GVSLQPGTTQ ICTQTDPFQQ TFIVCPPAFQ
     TGLQATTKHS GFPVRMDNAV PLVPQAPAAQ PLQIQSGVLT QGSCTPLMVA TLHPQVATIT
     PQYAVPFTLS CAAGRPALVE QTAAVQQAWP GGTQQILLPS AWQQLPGVAL HNSVQPTAVI
     PEAMGSSQQL ADWRNAHSHG NQYSTIMQQP SLLTNHVTLA TAQPLNVGVA HVVRQQQSSS
     LPSRKNKQSA PVSSTSSLEV LPSQVYSLVG SSPLRTTSSY NSLVPVQDQH QPIIIPDTPS
     PPVSVITIRS DTDEEEDNKF KPSSSSLKAR SNVISYVTVN DSPDSDSSLS SPYPTDTLSA
     LRGNSGTLLE GPGRTAADGI GTRTIIVPPL KTQLGDCTGA TQASGLLSSS KTKPVASVSG
     QSSGCCITPT GYRAQRGGAS AVQPLNLSQN QQSSSASTSQ ERSSNPAPRR QQAFVAPLSQ
     APYAFQHGSP LHSTGHPHLA PAPAHLPSQP HLYTYAAPTS AAALGSTSSI AHLFSPQGSS
     RHAAAYTTHP STLVHQVPVS VGPSLLTSAS VAPAQYQHQF ATQSYIGSSR GSTIYTGYPL
     SPTKISQYSY L
//
